Frankfurt - Delayed Quote EUR
Terns Pharmaceuticals Inc (430.F)
As of 8:05 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Terns Pharmaceuticals Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Terns Pharmaceuticals Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 12, 2024 at 1:30 PM UTC - November 18, 2024 at 1:30 PM UTC
Terns Pharmaceuticals Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
J7Z.F Jazz Pharmaceuticals plc
103.50
-0.72%
0RK.F Exscientia plc
4.6000
-2.08%
20D0.F Cidara Therapeutics, Inc.
10.20
0.00%
38I.F Intellia Therapeutics, Inc.
18.80
-2.67%
J90.F NurExone Biologic Inc.
0.3500
-7.41%
VX1.F Vertex Pharmaceuticals Incorporated
440.55
-0.44%
1VT.F Viking Therapeutics, Inc.
59.10
-0.17%
NRX.V NurExone Biologic Inc.
0.5400
0.00%
XBIO Xenetic Biosciences, Inc.
3.7650
+1.76%
CDTX Cidara Therapeutics, Inc.
11.22
-0.36%